Drug-labels.com

Mar-Dapsone: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
100 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mar-Dapsone

What is MAR-DAPSONE used for?

MAR-DAPSONE is used to treat

  • leprosy
  • dermatitis herpetiformis (a skin condition)
  • actinomycotic mycetoma (a fungal disease)

This medication is sometimes prescribed for other uses; ask your doctor for more information.

Antibacterial drugs like MAR-DAPSONE treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, MAR-DAPSONE should be used exactly as directed. Misuse or overuse of MAR-DAPSONE could lead to the growth of bacteria that will not be killed by MAR-DAPSONE (resistance). This means that MAR-DAPSONE may not work for you in the future. Do not share your medicine.

How does MAR-DAPSONE work?

  • MAR-DAPSONE works by killing the bacteria or fungi causing your infection.
  • When used for the treatment of dermatitis herpetiformis (a skin condition), Dapsone reduces the skin blisters and skin itch.

What are the ingredients in MAR-DAPSONE?

Medicinal ingredient: Dapsone

Non-medicinal ingredients: silica colloidal anhydrous, maize starch, magnesium stearate and microcrystalline Cellulose.

MAR-DAPSONE comes in the following dosage forms:

Tablet 100 mg

Do not use MAR-DAPSONE if:

  • You are allergic to MAR-DAPSONE, to sulfones, or to any ingredient in this formulation. (See

What are the ingredients in MAR-DAPSONE)

  • You have high amyloid levels or advanced amyloidosis of the kidneys.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MAR-DAPSONE. Talk about any health conditions or problems you may

have, including if you have:

  • heart problems
  • lung disease
  • liver disease
  • kidney problems
  • anemia
  • lack of the enzyme glucose-6-phosphate dehydrogenase in the body, so that red blood cells don’t work properly.

MAR-DAPSONE may cause blood cell problems such as:

  • Hemolytic anemia - red blood cells are destroyed so that they do not do their job carrying oxygen in the body
  • Methemoglobinemia – where a high amount of methemoglobin is made in the blood, and this prevents oxygen release into body tissues
  • Lack of the enzyme glucose-6-phosphate dehydrogenase can worsen the above blood cell problems.

Your doctor will do routine blood work during MAR-DAPSONE treatment to watch for blood problems and changes in liver function.

Other warnings you should know about:

Don’t use MAR-DAPSONE while pregnant unless advised by your doctor. If you become pregnant while taking MAR-DAPSONE, tell your doctor immediately.

MAR-DAPSONE is excreted in breast milk. Your doctor will decide with you if you should continue breastfeeding or stop taking MAR-DAPSONE.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with MAR-DAPSONE:

  • rifampicin
  • probenecid
  • chloroquine
  • primaquine

These medicines may be affected by MAR-DAPSONE, or may affect how well it works. You may need to take different amounts of your medicine, or you may need to take different medicines. Your healthcare professional will advise you.

How to take MAR-DAPSONE:

Take MAR-DAPSONE at the same time each day. The tablet should be swallowed with a full glass of water, with or after food.

MAR-DAPSONE should be taken exactly as directed, for as long as your healthcare professional tells you to. Do not stop taking MAR-DAPSONE even if you begin to feel better, unless advised by your healthcare professional.

Usual dose:

Leprosy:

When used for the treatment of leprosy, MAR-DAPSONE is usually taken with one or more other drugs, to prevent the development of resistance.

The usual dose of MAR-DAPSONE in adults is 100 mg daily. MAR-DAPSONE dosing in children is based on the child’s body weight.

Dermatitis Herpetiformis:

The usual adult dose is 50 mg to 100 mg MAR-DAPSONE daily, but a dose as little as MAR-DAPSONE 50 mg once a week may be adequate.

Actinomycotic Mycetoma:

The usual adult dose is 100 mg MAR-DAPSONE taken twice a day.

Overdose:

If you think you have taken too much MAR-DAPSONE, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you missed a dose of this medication, take it as soon as you remember. This will help to keep a constant amount of medication in your blood. But, if it is almost time for your next dose, skip the missed dose, and continue with your next scheduled dose. Do not take two doses at the same time.

What are possible side effects from using MAR-DAPSONE?

These are not all the possible side effects you may feel when taking MAR-DAPSONE. If you experience any side effects not listed here, contact your healthcare professional. Please also see Warnings and Precautions.

MAR-DAPSONE may cause:

  • loss of appetite
  • nausea
  • vomiting
  • headache
  • dizziness
  • nervousness
  • difficulty sleeping

Serious side effects and what to do about them

Symptom / effect

Talk to your healthcare

professional

Stop taking drug and get immediate medical help
Only if severeIn all cases

COMMON

Anemia symptoms (ie: hemolysis,

methemoglobinemia)

  • rapid heart rate
  • shortness of breath
  • unusual tiredness or weakness
  • jaundice, or yellowing of the skin and eyes
  • dark coloured urine
  • bluish colouring of the skin
√

UNCOMMON

Low white blood cell symptoms

  • persistent fever
  • chills
  • increased infections (eg sore throat, mouth sores, swollen lymph glands)
  • weakness
  • bleeding gums
√
Mood or other mental changes√
Numbness, tingling, pain, burning or weakness in hands and feet√

RARE

Hypersensitivity reaction

  • fever
  • flu-like symptoms
  • rash
√

Skin reactions

  • severe skin rash
  • itching, redness, scaling or peeling of skin
  • painful blisters
√

Kidney problems

  • back pain
  • swollen, puffy skin especially in the

    face, arms, legs (feet and ankles) and belly area

  • change in appearance of urine
  • painful and frequent urination
√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Protect from light. Store at 20 °C to 25 °C. Keep out of reach and sight of children.

If you want more information about MAR-DAPSONE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); the manufacturer’s website www.marcanpharma.com, or by calling 1-855-627-2261.

Date Prepared: September 21, 2018

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02481227

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mar-Dapsone

Rx or OTC
Prescription (Rx)?
DIN 02481227
Schedule(s) PRESCRIPTION
Active ingredient(s) Dapsone 100 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J04 Antimycobacterials
      1. J04B Drugs for treatment of lepra
        1. J04BA Drugs for treatment of lepra
          1. J04BA02 Dapsone
Company MARCAN PHARMACEUTICALS INC
Current status Marketed
Current status date November 13, 2018

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.